Cargando…
The Biofilm Inhibitor Carolacton Enters Gram-Negative Cells: Studies Using a TolC-Deficient Strain of Escherichia coli
The myxobacterial secondary metabolite carolacton inhibits growth of Streptococcus pneumoniae and kills biofilm cells of the caries- and endocarditis-associated pathogen Streptococcus mutans at nanomolar concentrations. Here, we studied the response to carolacton of an Escherichia coli strain that l...
Autores principales: | Donner, Jannik, Reck, Michael, Bunk, Boyke, Jarek, Michael, App, Constantin Benjamin, Meier-Kolthoff, Jan P., Overmann, Jörg, Müller, Rolf, Kirschning, Andreas, Wagner-Döbler, Irene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615136/ https://www.ncbi.nlm.nih.gov/pubmed/28959742 http://dx.doi.org/10.1128/mSphereDirect.00375-17 |
Ejemplares similares
-
Complete Genome Sequences of Three Multidrug-Resistant Clinical Isolates of Streptococcus pneumoniae Serotype 19A with Different Susceptibilities to the Myxobacterial Metabolite Carolacton
por: Donner, Jannik, et al.
Publicado: (2017) -
The biofilm inhibitor Carolacton inhibits planktonic growth of virulent pneumococci via a conserved target
por: Donner, Jannik, et al.
Publicado: (2016) -
The natural product carolacton inhibits folate-dependent C1 metabolism by targeting FolD/MTHFD
por: Fu, Chengzhang, et al.
Publicado: (2017) -
Mutations in the TolC Periplasmic Domain Affect Substrate Specificity of the AcrAB-TolC Pump
por: Marshall, Robert L., et al.
Publicado: (2020) -
Carolacton Treatment Causes Delocalization of the Cell Division Proteins PknB and DivIVa in Streptococcus mutans in vivo
por: Reck, Michael, et al.
Publicado: (2016)